BARAN, S. W.; BROWN, P. C.; BAUDY, A. R.; FITZPATRICK, S. C.; FRANTZ, C.; FULLERTON, A.; GAN, J.; HARDWICK, R. N.; HILLGREN, K. M.; KOPEC, A. K.; LIRAS, J. L.; MENDRICK, D. L. .; NAGAO, R.; PROCTOR, W. R. .; RAMSDEN, D.; RIBEIRO, A. J. S.; STRESSER, D.; SUNG, K. E. .; SURA, R.; TETSUKA, K.; TOMLINSON, L.; VAN VLEET, T.; WAGONER, M. P. .; WANG, Q.; ARSLAN, S. Y. .; YODER, G.; EKERT, J. E. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate). ALTEX - Alternatives to animal experimentation, [S. l.], v. 39, n. 2, p. 297–314, 2022. DOI: 10.14573/altex.2112203. Disponível em: https://www.altex.org/index.php/altex/article/view/2406. Acesso em: 26 jun. 2022.